Stuka Paul 4/A
4/A · InspireMD, Inc. · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Paul Stuka Buys 75,626 Shares
What Happened
- Paul Stuka, a director of InspireMD, acquired a total of 75,626 shares of InspireMD common stock in two open-market purchases: 65,626 shares on 2026-05-08 (weighted avg. $1.16; $76,126) and 10,000 shares on 2026-05-11 (weighted avg. $1.19; $11,900). Total consideration for the two purchases was roughly $88,026. These were purchases (insider buys), not sales.
Key Details
- Transaction dates & prices:
- 2026-05-08: 65,626 shares at $1.16 (weighted avg.; prices ranged $1.15–$1.16) — Footnote F1
- 2026-05-11: 10,000 shares at $1.19 (weighted avg.; prices ranged $1.17–$1.20) — Footnote F4
- Shares owned after the transaction (per amended filing): directly beneficially owned 632,871 shares (557,245 prior to these purchases + 75,626 acquired); indirectly beneficially owned 423,704 shares through Osiris — Footnotes F2, F3
- Holdings through Osiris: Osiris holds securities reported here; Stuka is managing member of Osiris Partners, LLC and may be deemed to beneficially own those shares but disclaims ownership except as to pecuniary interest — Footnote F5
- Filing/amendment notes: This is an amended Form 4 (filed 2026-05-13) correcting prior reporting (including beneficial ownership details) and to state the trades were NOT made pursuant to a Rule 10b5-1 trading plan (original Form 4 was filed on 2026-05-12 and inadvertently checked the 10b5-1 box) — Footnotes F2, F3, F6. The amendment did not change the economic interest.
Context
- Insider purchases are often watched by investors as a potentially bullish signal because insiders are adding to holdings, but they do not guarantee future stock performance. These were open-market purchases by a company director and not option exercises, gifts, or sales. Information about exact per-trade prices within the reported ranges can be provided by the reporting person upon request (per footnotes).
Insider Transaction Report
Form 4/AAmended
InspireMD, Inc.NSPR
Stuka Paul
Director
Transactions
- Purchase
Common Stock
[F6][F1][F2][F3]2026-05-08$1.16/sh+65,626$76,126→ 622,871 total - Purchase
Common Stock
[F6][F4]2026-05-11$1.19/sh+10,000$11,900→ 632,871 total
Holdings
- 423,704(indirect: See Footnote)
Common Stock
[F2][F3][F5]
Footnotes (6)
- [F1]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]The Form 4 filed on August 1, 2025 (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. ("Osiris"). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
- [F3]This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
- [F4]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]These securities are held by Osiris. The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F6]This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the "Original Filing") inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
Signature
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka|2026-05-13